Compare ALRS & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALRS | AQST |
|---|---|---|
| Founded | 1879 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 608.0M | 707.6M |
| IPO Year | 2019 | 2018 |
| Metric | ALRS | AQST |
|---|---|---|
| Price | $23.70 | $3.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $25.00 | $8.83 |
| AVG Volume (30 Days) | 137.0K | ★ 6.3M |
| Earning Date | 01-28-2026 | 03-04-2026 |
| Dividend Yield | ★ 3.54% | N/A |
| EPS Growth | ★ 1114.87 | N/A |
| EPS | ★ 1.95 | N/A |
| Revenue | ★ $275,452,000.00 | $43,397,000.00 |
| Revenue This Year | $43.78 | N/A |
| Revenue Next Year | $4.60 | $43.02 |
| P/E Ratio | $12.15 | ★ N/A |
| Revenue Growth | ★ 67.44 | N/A |
| 52 Week Low | $15.78 | $2.12 |
| 52 Week High | $25.00 | $7.55 |
| Indicator | ALRS | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 26.11 |
| Support Level | $23.25 | $3.17 |
| Resistance Level | $25.00 | $3.55 |
| Average True Range (ATR) | 0.73 | 0.28 |
| MACD | -0.04 | -0.09 |
| Stochastic Oscillator | 41.23 | 6.41 |
Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.